Delivery included to the United States

Decoding Aurobindo Pharma's Financial Health. A Four-Year Analytical Study (2021-2024)

Decoding Aurobindo Pharma's Financial Health. A Four-Year Analytical Study (2021-2024)

Paperback (23 Apr 2025)

Save $9.49

  • RRP $48.44
  • $38.95
Add to basket

Includes delivery to the United States

10+ copies available online - Usually dispatched within 7 days

Publisher's Synopsis

Research Paper (undergraduate) from the year 2024 in the subject Economics - Finance, grade: A, course: B.Com (Honors) Strategic Finance, language: English, abstract: This project takes a closer look at the financial performance of Aurobindo Pharma, using different financial tools and techniques. We dive into aspects like the company's liquidity, profitability, solvency, and efficiency over four years (2021-2024), by examining key financial statements such as the balance sheet, income statement, and cash flow statement. For the study, several methods include ratio analysis, common size analysis, comparative analysis, and trend analysis to evaluate financial stability and growth patterns. The results provide insights into the company's financial health, pointing out strengths, weaknesses, and areas where improvements can be made. This study acts as a useful resource for investors, management, and stakeholders to help them make knowledgeable financial decisions.

Book information

ISBN: 9783389137239
Publisher: Bod Third Party Titles
Imprint: Grin Verlag
Pub date:
Language: English
Number of pages: 56
Weight: -1g
Height: 210mm
Width: 148mm
Spine width: 3mm